How Will Obama Care Affect the Pharmaceutical Industry?

The biggest health care reform act since Medicareinformed industry observers believe that the industry
was created in 1965 has just been signed by thewon't be in any worse shape than it suffered during
President- amidst more controversy than any billthe Clinton era when scrutiny was very high, or more
passed in the last twenty years. How will this affectrecently when the sector came under significant
the pharmaceutical industry?criticism for huge profits during the period of
This bill is estimated to carry a $940B price tag, buteconomic corrections
will insure an additional 32M Americans by 2019.As pharmaceutical consulting firms point out, patents
However, it does include hefty taxes - over $70B,have expired, and generic availability has increased,
and HMOs. Insurance companies won't be able tomeaning the industry has been forced to become
deny new customers based on pre-existingmore "lean and mean". in its approach to generating
conditions, and companies with over 200 workers willrevenues.
have to automatically enroll employees in some formThis bill hits the industry with over $10B in increased
of insurance coverage.taxes to pay for the expanded insurance coverage
Although government subsidies for the uninsuredpromised. This is probably going to offset at least
won't kick in until 2014, costs will be incurred almostsome of the gains made as a result of having a
immediately, which is why many have opposed thislarger available customer base. And it has been
plan. Cuts in Medicare will also be used to partiallyargued that more expensive, and controversial
fund the bill, and this is causing concern in certaintreatments that would have led to miracle cures,
quarters as Medicare is considered to be a "sacredsaved lives and higher profit margins will be slower to
cow" to many.reach the market under this plan.
Although many are questioning the effect this willGiven the length of time it will take to create
have on the development of new medicines,insurance coverage for these millions of Americans
pharmaceutical companies large and small arewho stand to benefit under the bill, it will take some
expected to be the big winners in the end, as manytime before the expected benefits will accrue. In the
more people will be insured and able to affordmeantime, we can expect the pharmaceutical giants
life-saving medications, new treatments, andto continue their consolidation by purchasing smaller
maintenance medications that would have beencompanies, expansion into new and emerging
simply too expensive for them before this legislationmarkets, and lobbying for greater protection from
was enacted.cheap, foreign-made "knock-off" drugs that are
Democratic leaders are claiming that whenever adangerous to both patients and branded drugs profit
business sector gains a larger customer base, it wins!margins.
Obama Care is no exception to this rule, as manyWe can also expect the Obama Care controversy to
more children and elderly will gain coverage which willpersist long after the ink has dried on the signed
increase the number of prescriptions for medicineslegislation, as opponents protest over loss of
and other health care services.freedoms, and proponents rejoice at the expansion
The amount of money, time and energy spent byof coverage. We can only hope that the promised
Big Pharma in promoting this bill has left the Americanbenefits actually happen, and are not watered down
public suspicious and a bit cynical about industryby amendments that are almost certain to follow.
intentions. Will this tarnish industry perceptions? Most